Wamberg Genomic Advisors and Global Healthcare Resources Announce Partnership to Deliver Genomic Testing to Insurance Professionals and Employer Groups

05:46 EDT 1 Aug 2017 | PR Newswire

PALM BEACH GARDENS, Fla., Aug. 1, 2017 /PRNewswire/ -- Wamberg Genomic Advisors (WGA) and Global Healthcare Resources (GHR) announced today a new partnership to bring genomic testing to insurance professionals and employer groups. By educating insurance professionals about the potential of genetic testing and integrating these tests into employee benefit packages, this partnership hopes to create a healthier workforce that is engaged in, and informed of, their health.

The advent of genetic testing promises to revolutionize healthcare as we understand it. By using genetic tests, individuals are informed of their current and future health status and can create a personalized health plan tailored to their unique genetic profile.  Ultimately, this will empower individuals to engage in their health and make better decisions regarding their health leading to longer lives for individuals and reduced healthcare costs for employers.

"We are thrilled to announce this partnership," said Tom Wamberg, CEO of WGA. "By working with GHR to enter the employer and insurance markets, we can not only help individuals unlock the potential of their health, we can further the power of genetic tests. As more people have their genetics sequenced, the industry as a whole will be able to provide additional insights and more accurate predictions as we better understand the genetic components of disease."

WGA and GHR are working together to not only improve health decisions but to help employees catch diseases such as cancer in their early stages, where treatment is both easier and more affordable. A typical cancer diagnosis and treatment in the U.S. will cost well over $150,000 on average, with some of the newest drugs costing $10,000 or more a month. Advanced cancer genomic profiling uses techniques such as DNA sequencing to identify mutations found in a patients cancer that can add significantly to an Oncologist's ability to more rapidly identify the most effective treatment options.

"Genetic testing is the future of healthcare," said Jonathan Edelheit, CEO of GHR. "These tests will change how we utilize healthcare, from knowing exactly what drugs work best for you, to what health concerns you should be on the lookout for in the future. By bringing these services to employer groups as part of their employer sponsored plans, or as a voluntary benefit, we can optimize our healthcare system and make employees across the world more engaged in their health."

About Wamberg Genomic Advisors

Wamberg Genomic Advisors is your partner in the Genomic Revolution. Our mission is to deliver genomic products and services to policyholders of life insurance companies, employers, and their employees via their trusted benefit brokers. To discover more about WGA, and what the future of genomics will look like, visit

About Global Healthcare Resources

Global Healthcare Resources is the leader in providing marketing and training services in international healthcare for healthcare providers, insurance companies, & governments. For more information about getting your product or service in front of employer groups and insurance professionals, visit

Contact Information

Wamberg Genomic Advisors 
Erin Stalker   

Lynnette Bates

Global Healthcare Resources
Daniel Pyne
561.544.7123 ext. 805

View original content:

SOURCE Global Healthcare Resources


More From BioPortfolio on "Wamberg Genomic Advisors and Global Healthcare Resources Announce Partnership to Deliver Genomic Testing to Insurance Professionals and Employer Groups"

Quick Search

Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...